Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000235776

Medchemexpress LLC (2S)-2-[[3-cyclobutyl-5-(3,4,5-trifluorophenoxy)imidazo[4,5-b]pyridin-2-yl]methylamino]propanamide | 1233231-30-5 | 98.3% | 419.4 g/mol | C20H20F3N5O2 | 100MG
SDP

Supplier:  Medchemexpress LLC HY125079100MG

Encompass_Preferred

DSP-2230 (ANP-230) is an orally active small-molecule inhibitor of voltage-gated sodium channels with activity against Nav1.7, Nav1.8, and Nav1.9. It is commonly used in preclinical research on neuropathic pain and sodium channel pharmacology, and is supplied at research-grade purity for in vitro and in vivo studies.

  • Inhibits Nav1.7, Nav1.8, and Nav1.9 with reported IC50s of 7.1 μM, 11.4 μM, and 6.7 μM respectively.
  • High purity suitable for research use (≈98.3%).
  • Small-molecule structure with molecular weight 419.4 g/mol.
  • Soluble in DMSO for assay preparation.
  • Available in multiple pack sizes to support dose-ranging and scaling studies.

Catalog No. 50-002-35776


May include imposed supplier surcharges.
Only null left
Add to Cart

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.